{"name": "Covagen",
 "permalink": "covagen",
 "crunchbase_url": "http://www.crunchbase.com/company/covagen",
 "homepage_url": "http://www.covagen.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": 1,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "41(0)44 635 60 33",
 "description": "Protein Therapeutics",
 "created_at": "Tue Dec 01 19:59:44 UTC 2009",
 "updated_at": "Tue Nov 30 03:26:32 UTC 2010",
 "overview": "\u003Cp\u003ECovagen AG develops protein-based therapeutics for the treatment of inflammatory diseases and cancer. Its products enable the isolation of high affinity protein-based binders called Fynomers, which changes the activity of target molecules relevant in various diseases. Covagen AG was founded in 2007 and is based in Z\u00c3\u00bcrich, Switzerland.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       28],
      "assets/images/resized/0006/8168/68168v1-max-150x150.jpg"],
     [[250,
       48],
      "assets/images/resized/0006/8168/68168v1-max-250x250.jpg"],
     [[311,
       60],
      "assets/images/resized/0006/8168/68168v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$40.5M",
 "funding_rounds":
  [{"round_code": "seed",
    "source_url": "http://www.covagen.com/index.php?id=85",
    "source_description": "Covagen",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2009,
    "funded_month": 10,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MP Healthcare Venture Management",
         "permalink": "mp-healthcare-venture-management-inc",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0005/0688/50688v3-max-150x150.png"],
             [[250,
               29],
              "assets/images/resized/0005/0688/50688v3-max-250x250.png"],
             [[450,
               52],
              "assets/images/resized/0005/0688/50688v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020100109e61b0002t\u0026r=Rss\u0026s=DJFVLS",
    "source_description": "Covagen Extends Seed Funds, Plans For $34M Series A",
    "raised_amount": 34200000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 12,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Ventech",
         "permalink": "ventech-capital",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0002/9792/29792v4-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0002/9792/29792v4-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0002/9792/29792v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.covagen.com/index.php?id=92",
    "source_description": "Covagen closes Series A financing round with Seroba Kernel as lead investor",
    "raised_amount": 6300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 11,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Seroba Kernel",
         "permalink": "seroba-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               34],
              "assets/images/resized/0007/6008/76008v2-max-150x150.png"],
             [[250,
               57],
              "assets/images/resized/0007/6008/76008v2-max-250x250.png"],
             [[274,
               63],
              "assets/images/resized/0007/6008/76008v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Edmond de Rothschild Venture Capital",
         "permalink": "edmond-de-rothschild-venture-capital",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0001/6998/16998v7-max-150x150.png"],
             [[250,
               83],
              "assets/images/resized/0001/6998/16998v7-max-250x250.png"],
             [[292,
               98],
              "assets/images/resized/0001/6998/16998v7-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MP Healthcare Venture Management",
         "permalink": "mp-healthcare-venture-management-inc",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0005/0688/50688v3-max-150x150.png"],
             [[250,
               29],
              "assets/images/resized/0005/0688/50688v3-max-250x250.png"],
             [[450,
               52],
              "assets/images/resized/0005/0688/50688v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Funds",
         "permalink": "novartis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               14],
              "assets/images/resized/0004/4137/44137v1-max-150x150.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-250x250.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Ventech",
         "permalink": "ventech-capital",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0002/9792/29792v4-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0002/9792/29792v4-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0002/9792/29792v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Y17 M22, Life Science ETH/Uni",
    "address2": "Winterthurerstrasse 190",
    "zip_code": "8057",
    "city": "Z\u00c3\u00bcrich",
    "state_code": null,
    "country_code": "CHE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0007/2974/72974v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0007/2974/72974v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0007/2974/72974v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}